Chemistry: natural resins or derivatives; peptides or proteins; – Peptides of 3 to 100 amino acid residues
Reexamination Certificate
2007-04-10
2007-04-10
Hill, Myron G. (Department: 1648)
Chemistry: natural resins or derivatives; peptides or proteins;
Peptides of 3 to 100 amino acid residues
C530S350000, C435S069100, C435S320100, C536S023400, C536S023720
Reexamination Certificate
active
09972035
ABSTRACT:
Isolated protein complexes are provided comprising Tsg101 and HIV GAGp6. The protein complexes are useful in screening assays for selecting compounds effective in modulating the Tsg101-HIV GAGp6 interaction within the protein complexes.
REFERENCES:
patent: 5807995 (1998-09-01), Cohen et al.
patent: 5891668 (1999-04-01), Li et al.
patent: 5892016 (1999-04-01), La Brie et al.
patent: 6248523 (2001-06-01), Cohen et al.
patent: 6274312 (2001-08-01), Gish et al.
patent: 2003/0049607 (2003-03-01), Greener et al.
patent: WO 02/094314 (2002-11-01), None
Strack PNAS Nov. 2000 vol. 97, No. 24 pp. 13063-13068.
Patniak PNAS Nov. 2000 vol. 97, No. 24 pp. 1369-13074.
Ott et alJ. Virol. 1998 72: 2962-2968.
Heinrichs et al., 1997 PNAS 94: 115-120.
Desai et al., Proc Natl Acad Sci U S A. Nov. 1986;83(21):8380-4.
Parent, Leslie J., et al., “Positionally Independent and Exchangeable Late Budding Functions of the Rous Sarcoma Virus and Human Immunodeficiency Virus Gag Proteins”,Journal of Virology, Sep. 1995; 69(9):5455-5460.
NCBI Entrez Protein Database Accession No.: AAB38034, Dec. 5, 1996.
Zhang, Yi-Ming, et al., “Drug Resistance during Indinavir Therapy Is Caused by Mutations in the Protease Gene and in Its Gag Substrate Cleavage Sites”,Journal of Virology, Sep. 1997; 71 (9) :6662-6670.
Puffer, Bridget A., et al., “Equine Infectious Anemia Virus Utilizes a YXXL Motif within the Late Assembly Domain of the Gag p9 Protein”,Journal of Virology, Sep. 1997; 71 (9): 6541-6546.
NCBI Entrez Protein Database Accession No. AAB83138, Nov. 6, 1997.
NCBI Entrez Protein Database Accession No. AAB83216, Nov. 6, 1997.
NCBI Entrez Protein Database Accession No. AAB83821, Nov. 6, 1997.
Yasuda, Jiro, et al., “A Proline-Rich Motif (PPPY) in the Gag Polyprotein of Mason-Pfizer Monkey Virus Plays a Maturation-Independent Role in Virion Release”,Journal of Virology, May 1998; 72(5):4095-4103.
NCBI Entrez Protein Database Accession No. P35962, Jul. 15, 1998.
Crump, Colin M., et al., “Inhibition of the Interaction between Tyrosine-based Motifs and the Medium Chain Subunit of the AP-2 Adaptor Complex by Specific Tyrphostins”,The Journal of Biological Chemistry, Oct. 23, 1998; 273(43):28073-28077.
Puffer, Bridget A., et al., “Equine Infectious Anemia Virus Gag Polyprotein Late Domain Specifically Recruits Cellular AP-2 Adapter Protein Complexes during Virion Assembly”,Journal of Virology, Dec. 1998; 72(12):10218-10221.
Sorkina, Tatiana, et al., “Clathrin, adaptors and eps15 in endosomes containing activated epidermal growth factor receptors”,Journal of Cell Science, 1999; 112:317-327.
Yuan, Bing, et al., “Mutations altering the Moloney murine leukemia virus p12 Gag protein affect virion production and early events of the virus life cycle”,The EMBO Journal, 1999; 18(17):4700-4710.
NCBI Entrez Protein Database Accession No. AAD03232, Jan. 6, 1999.
NCBI Entrez Protein Database Accession No. AAD03240, Jan. 6, 1999.
U.S. Appl. No. 09/971,549, filed Oct. 4, 2001, Zavitz et al.
Garnier, Laurence, et al., “Identification of Retroviral Late Domains as Determinants of Particle Size”,Journal of Virology, Mar. 1999; 73(3):2309-2320.
Harty, Ronald N., et al., “A Proline-Rich Motif within the Matrix Protein of Vesicular Stomatitis Virus and Rabies Virus Interacts with WW Domains of Cellular Proteins: Implications for Viral Budding”,Journal of Virology, Apr. 1999; 73(4):2921-2929.
Craven, Rebecca C. et al., “Late Domain Function Identified in the Vesicular Stomatitis Virus M Protein by Use of Rhabdovirus-Retrovirus Chimeras”,Journal of Virology, Apr. 1999; 73(4):3359-3365.
Harvey, Kieran F., et al., “Nedd4-like proteins: an emerging family of ubiquitin-protein ligases implicated in diverse cellular functions”,Trends in Cell Biology, May 1999; 9:166-169.
Deschambeault, Julie, et al., “Polarized Human Immunodeficiency Virus Budding in Lymphocytes Involves a Tyrosine-Based Signal and Favors Cell-to-Cell Viral Transmission”,Journal of Virology, Jun. 1999; 73(6):5010-5017.
NCBI Entrez Protein Database Accession No. AAF35354, Feb. 23, 2000.
Alexander, Louis, et al., “Unusual Polymorphisms in Human Immunodeficiency Virus Type 1 Associated with Nonprogressive Infection”,Journal of Virology, May 2000; 74(9):4361-4376.
Butkiewicz, Nancy, et al., “Virus-Specific Cofactor Requirement and Chimeric Hepatitis C Virus/GB Virus B Nonstructural Protein 3”Journal of Virology, May 2000; 74(9):4291-4301.
Accola, Molly A., et al., “Efficient Particle Production by Minimal Gag Constructs Which Retain the Carboxy-Terminal Domain of Human Immunodeficiency Virus Type 1 Capsid-p2 and a Late Assembly Domain”,Journal of Virology, Jun. 2000; 74(12):5395-5402.
Yuan, Bing, et al., “Infectivity of Moloney Murine Leukemia Virus Defective in Late Assembly Events Is Restored by Late Assembly Domains of Other Retroviruses”,Journal of Virology, Aug. 2000; 74(16):7250-7260.
NCBI Entrez Protein Database Accession No. CAB92786, Sep. 20, 2000.
Jayakar, Himangi R., et al., “Mutations in the PPPY Motif of Vesicular Stomatitis Virus Matrix Protein Reduce Virus Budding by Inhibiting a Late Step in Virion Release”,Journal of Virology, Nov. 2000; 74(21):9818-9827.
Strack, Bettina, et al., “A role for ubiquitin ligase recruitment in retrovirus release”,PNAS, Nov. 21, 2000; 97(24):13063-13068.
Schubert, Ulrich, et al., “Proteasome Inhibition interferes with Gag polyprotein processing, release, and maturation of HIV-1 and HIV-2”,PNAS, Nov. 21, 2000; 97(24):13057-13062.
Patnaik, Akash, et al., “Ubiquitin is part of the retrovirus budding machinery”,PNAS, Nov. 21, 2000; 97(24):13069-13074.
Vogt, Volker M., “Ubiquitin in retrovirus assembly: Actor or bystander?”,PNAS, Nov. 21, 2000; 97(24):12945-12947.
Harty, Ronald N., et al., “A PpxY motif within the VP40 protein of Ebola virus interacts physically and functionally with a ubiquitin ligase: Implications for filovirus budding”,PNAS, Dec. 5, 2000; 97(25):13871-13876.
NCBI Entrez Protein Database Accession No. AAD17020, Jun. 1, 2001.
Verplank, Lynn, et al., “Tsg101, a homologue of ubiquitin-conjugating (E2) enzymes, binds the L domain in HIV type 1 Pr55Gag”,PNAS, Jul. 3, 2001; 98(14):7724-7729.
Garrus, Jennifer E., et al., “Tsg101 and the Vacuolar Protein Sorting Pathway Are Essential for HIV-1 Budding”,Cell, Oct. 5, 2001; 107:55-65.
Whittle, Peter J., et al., “Protein Structure-Based Drug Design”,Annu. Rev. Biophys. Biomol. Struct., 1994; 23:349-375.
Mhashilkar, Abner M., et al., “Inhibition of HIV-1 Tat-mediated LTR transactivation and HIV-1 infection by anti-Tat single chain intrabodies”,The EMBO Journal, 1995; 14(7):1542-1551.
Huang, Mingjun, et al., “p6GagIs Required for Particle Production from Full-Length Human Immunodeficiency Virus Type 1 Molecular Clones Expressing Protease”,Journal of Virology, Nov. 1995; 69(11):6810-6818.
Rossi, John J., “Therapeutic applications of catalytic antisense RNAs (ribozymes)”,CIBA Foundation Symposium, 1997; 209:195-204.
Levin, Reuven, et al., “Inhibition of Early and Late Events of the HIV-1 Replication Cycle by Cytoplasmic Fab Intrabodies against the Matrix Protein, p17”,Molecular Medicine, Feb. 1997; 3(2):96-110.
Savarino, Andrea, et al., “The Biochemistry of Gene Therapy for AIDS”,Clin. Chem. Lab. Med., 1998; 36(4):205-210.
Verkhivker, Gennady M., “Towards understanding the mechanisms of molecular recognition by computer simulations of ligand-protein interactions”,Journal of Molecular Recognition, 1999; 12:371-389.
Luban, Jeremy, “HIV-1 and Ebola virus: The gateway driver nabbed”,Nature Medicine, Dec. 2001; 7(12):1278:1280.
Martin-Serrano, Juan, et al., “HIV-1 and Ebola virus encode small peptide motifs that recruit TSG101 to sites of
Morham Scott
Wettstein Daniel Albert
Zavitz Kenton
Hill Myron G.
Ley, III Herbert I
Myriad Genetics Inc.
Myriad IP Department
Zhang Jay Z.
LandOfFree
Tsg101-GAGp6 interaction and use thereof does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Tsg101-GAGp6 interaction and use thereof, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Tsg101-GAGp6 interaction and use thereof will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3752518